October 29, 2019
Verastem Oncology Reports Third Quarter 2019 Financial Results and Recent Company Progress
Verastem Oncology has reported $9 Million in total revenue, including $4.0 Million in net product revenue from COPIKTRA®; Reaffirms FY2019…